Vivo Bio Tech Ltd share price logo

Vivo Bio Share Price

25.30

+0.61

(+2.47%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Vivo Bio Stock Performance

as on March 18, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹24.47
    ₹25.49
    downward going graph

    3.28%

    Downside

    0.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹22.90
    ₹44.70
    downward going graph

    9.49%

    Downside

    76.68%

    Upside

    downward going graph

Vivo Bio share price movements today

Previous Close
₹24.69
Open
₹24.47
Volume
13.92K
Upper Circuit
₹29.62
Lower Circuit
₹19.76
Day's Low - High
₹24.47 - ₹25.49
52 Week Low - High
₹22.90 - ₹44.70

Vivo Bio Historical Returns

1 Month Return
-11.6 %
3 Month Return
-12.45 %
1 Year Return
-32.52 %
3 Year Return
+ 9.34 %
5 Year Return
-53.55 %

Vivo Bio Fundamentals

as on March 18, 2026 at 4:01 pm IST

Market Cap

₹54.79 Cr

Return on Equity (ROE)

6.05

PE Ratio (TTM)

10.12

Return on capital employed (ROCE)

9.37

Industry PE ratio

41.1

Beta (LTM)

0.89

P/B Ratio

0.82

Dividend Yield

0

PEG Ratio

-4.54

Quarterly Earnings Growth YOY

52.44

EPS (TTM)

4.24

Sector

Pharmaceuticals

Book Value

41.15

Technical Analysis

Vivo Bio Stock Valuation

as on March 18, 2026 at 4:01 pm IST

Vivo Bio in the last 5 years

  • Overview

  • Trends

Lowest (-339.44x)

January 2, 2023

Today (10.12x)

March 17, 2026

Industry (41.10x)

March 17, 2026

Highest (48.33x)

October 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 10.12x

Vivo Bio Tech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivo Bio with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA54.79-10.71%0.71746
NA1,942.8715.72%0.53-9559
NA94.9916.07%0.008173
NA82.07-3.06%0.00244
BUY13,880.6517.41%0.645014,481

Vivo Bio Stock’s Investor Sentiment and Interest

Search interest for Vivo Bio Tech Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Vivo Bio Tech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
14.76
11.58
9.26
12.85
11.76
10.13
12.04
12.21
12.29
12.51
13.11
13.51
Other Income
0.02
-
-
0.03
0.01
0.01
4.63
0.01
0.15
0.14
0.13
0.14
Total Income
14.78
11.58
9.26
12.88
11.77
10.15
16.67
12.22
12.44
12.65
13.24
13.65
Expenses
7.63
7.1
4.4
6.47
6.39
5.77
6.44
6.67
7.28
7.02
7.7
8.02
Operating Profit
7.13
4.48
4.86
6.38
5.37
4.36
5.6
5.54
5.01
5.49
5.41
5.49
Operating Profit Margin %
48.31%
38.69%
52.48%
49.65%
45.66%
43.04%
46.51%
45.37%
40.76%
43.88%
41.27%
40.64%
Profit Before Interest, Tax and Depreciation
7.15
4.49
4.86
6.41
5.38
4.38
10.22
5.55
5.17
5.63
5.55
5.63
Interest
2.01
1.95
2.09
2.22
1.52
1.92
2.06
1.84
1.68
1.5
1.47
1.4
Depreciation
2.26
2.29
2.3
2.28
2.43
2.23
2.29
2.25
2.25
2.64
2.57
2.66
Profit Before Tax
2.88
0.25
0.47
1.91
1.43
0.23
5.87
1.46
1.24
1.49
1.51
1.57
Tax Paid
0.82
0.11
0.14
0.59
0.7
0.06
0.63
0.64
0.18
0.14
0.64
0.32
Profit After Tax
2.06
0.14
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
Total Net profit including share of profit / Loss from associate company
2.06
0.14
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
EPS
1.38
0.1
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
Actual EPS
1.38
0.1
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
Adjusted EPS
1.38
0.1
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
Diluted EPS
1.38
0.1
0.22
0.89
0.31
0.11
3.51
0.55
0.69
0.74
0.45
0.56

Vivo Bio Tech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
47
55.83
55.35
51.78
51.39
52.23
45.45
46.67
Other Income
0.13
0.01
0.05
0.08
0.1
0.04
0.04
4.8
Total Income
47.13
55.85
55.41
51.85
51.49
52.27
45.49
51.48
Expenses
36.12
46.32
42.88
34.11
35.58
30.73
24.36
26.16
Operating Profit
10.88
9.51
12.47
17.67
15.81
21.5
21.09
20.51
Operating Profit Margin %
23.15%
17.03%
22.53%
34.13%
30.76%
41.16%
46.4%
43.95%
Profit Before Interest, Tax and Depreciation
11.01
9.53
12.52
17.74
15.91
21.54
21.13
25.31
Interest
2.37
2.64
3.1
3.53
3.99
7.65
7.78
7.5
Depreciation
4.64
5.06
5.17
5.59
7.45
9.27
9.29
9.02
Profit Before Tax
4
1.83
4.25
8.62
4.47
4.62
4.06
8.79
Tax Paid
0.88
-0.42
-0.19
2.94
2.27
1.97
1.54
1.51
Profit After Tax
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
Total Net profit including share of profit / Loss from associate company
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
Actual EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
Adjusted EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
Diluted EPS
2.36
1.76
3.45
4.19
1.56
1.78
1.51
4.76

Vivo Bio Tech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
8.81
-5.66
11.11
-0.78
8.61
14.18
16.64
14.83
15.52
11.83
Cash Flow from Investing Activities
-7.2
-11.84
-4.72
-3.53
-10.23
-22.82
-51.11
-4
-7.95
-15.84
Cash Flow from Financing Activities
-0.32
6.83
-3.43
0.72
2.09
8.78
35.02
-11.17
-7.55
3.9
Net Cash Flow
1.3
-10.67
2.96
-3.59
0.47
0.14
0.55
-0.34
0.01
-0.11

Vivo Bio Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Apr 2025
May 2025
Jun 2025
Aug 2025
Sep 2025
Dec 2025
Promoters
42.08%
42.08%
42.08%
42.08%
42.08%
42.08%
38.88%
40.85%
43.36%
42.29%
39.06%
36.43%
35.16%
35.16%
Public
57.92%
57.92%
57.92%
57.92%
57.92%
57.92%
61.12%
59.15%
56.64%
57.71%
60.94%
63.57%
64.84%
64.84%
Total Outstanding Shares
1,49,03,520
1,49,03,520
1,49,03,520
1,49,03,520
1,49,03,520
1,49,03,520
1,61,28,520
1,71,64,816
1,79,24,816
1,83,78,149
1,98,93,889
2,13,33,221
2,21,00,628
2,21,00,628
Total Shareholders
12,989
13,006
15,615
18,971
18,852
19,545
21,167
21,935
21,935
21,909
21,865
21,890
21,647
21,622

Vivo Bio Corporate Actions

View detailed summary of the earnings and dividend history of Vivo Bio.

  • Vivo Bio Tech Ltd Earnings Results

    Vivo Bio Tech Ltd’s net profit jumped 52.44% since last year same period to ₹1.25Cr in the Q3 2025-2026. On a quarterly growth basis, Vivo Bio Tech Ltd has generated 43.68% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Vivo Bio Tech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 12.22 Cr → 13.65 Cr (in ₹), with an average increase of 2.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Vivo Bio Tech stock has moved up by 7.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.87 Cr → 1.25 Cr (in ₹), with an average increase of 30.4% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.16% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Biocon Ltd has given 12.3% return, outperforming this stock by 44.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 64.84% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 182.3% return, outperforming this stock by 173.0%

About Vivo Bio Tech Ltd

Vivo Bio Tech is a full service CRO that provides a range of drug development and discovery services tailored to the needs of global pharmaceutical and biotechnology companies in accordance with OECD AAALAC IND guidelines. With experienced and talented scientists, our services include In vitro and In vivo toxicity studies, pharmacological investigations, pharmacokinetics, toxicokinetic studies, gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Additionally, we offer services for pharmacologic, toxicological and bioanalytical investigations for drug discovery and development, including bacterial reverse mutation assays, chromosomal aberration and micronucleus. Our Invivo Services group provides both nonregulatory and regulatory IND enabling preclinical development services as well as design and development of xenograft models for evaluation of anticancer agents. We have also partnered with Taconic for sourcing foundation and expansion colonies of animal models, in addition to beginning in-house breeding of Specific Pathogen Free rodents.

Revenue: ₹13.51Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1.25Cr as on December 2025 (Q3 FY26)
Chairperson Name: K Sunder
OrganisationVivo Bio Tech Ltd
HeadquartersSecunderabad
IndustryPharmaceuticals
CEOK Sunder
E-voting on sharesClick here to vote

FAQs

What is Vivo Bio share price today?

Vivo Bio share price today stands at ₹25.3 as on at the close of the market. Vivo Bio share today touched a day high of ₹25.49 and a low of ₹24.47.

What is the 52 week high and 52 week low range for Vivo Bio share?

Vivo Bio touched a 52 week high of ₹44.7 and a 52 week low of ₹22.9. Vivo Bio share price today i.e. is closed at ₹25.3, which is -43.40% down from its 52 week high and 10.48% up from its 52 week low.

What is Vivo Bio's market capitalisation today?

Vivo Bio market capitalisation is ₹54.79 Cr as on .

How to buy Vivo Bio shares?

To buy Vivo Bio shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 511509 or Vivo Bio Tech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vivo Bio shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vivo Bio trading volume today?

Vivo Bio trading volume is 13.92K as on . This means that 13.92K shares of Vivo Bio were bought and sold on the stock market during today's trading session.